| 摘要 |
<p>The invention relates to the field of (veterinary) medicine and to the treatment of subjects (be it man or animal) that suffer from iatrogenic disease, i.e. experience problems or complications resulting from a medical treatment. The invention provides a method for modulating an iatrogenic event in a subject comprising providing said subject with a gene-regulatory peptide or functional analogue thereof. Furthermore, the invention provides use of an NF-kappaB down-regulating peptide or functional analogue thereof for the production of a pharmaceutical composition for the treatment of an additional pro-inflammatory cytokine response occurring after an iatrogenic event in a subject.</p> |
